Aktis Oncology, Inc. Common stock

AKTS us
$19.43
▼ 0.20 (-1.02%)
Volume: 518,910 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 13
  • 21d momentum -26.7%
  • MA aligned bearish
  • RSI 28 oversold
🎯 Pullback 69
  • RSI 28 near lows
  • Near lower Bollinger band
  • -17.3% vs 20MA
💎 Value 58
  • -43% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)27.9
MACD-0.509
MA trendBearish
ATR7.02%
21d mom.-26.7%
63d mom.-34.0%
vs 20MA-17.3%
RVOL(20)1.08×
52w low · 0 52w high · 34
-43.2% from 52-week high
20d support 19 · resistance 28

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap—
PER—
PBR—
PSR—
EPS—
ROE—
ROA—
Dividend yield—
Debt/Equity—
EV/EBITDA—
week1M3M6M1YYTD
-11.20% -26.71% -34.00% +10.27% — -13.26%

Valuation and profitability in USD. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
0/10
🐻 Bear
10/10

14d momentum -28.17%, daily vol 3.39%. Aktis Oncology, Inc. Common stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.